A randomized trial studied 242 HIV-positive pregnant women in their second trimester to assess the efficacy of zidovudine (AZT) in preventing transmission of HIV from mother to child. The results showed that AZT was effective in reducing perinatal transmission of HIV.
A randomized trial studied 242 HIV-positive pregnant women in their second trimester to assess the efficacy of zidovudine (AZT) in preventing transmission of HIV from mother to child. The results showed that AZT was effective in reducing perinatal transmission of HIV.
A randomized trial studied 242 HIV-positive pregnant women in their second trimester to assess the efficacy of zidovudine (AZT) in preventing transmission of HIV from mother to child. The results showed that AZT was effective in reducing perinatal transmission of HIV.
HIV- seropositive, 2nd-trimester pregnant women to assess the efficacy of zidovudine(AZT ) in preventing perinatal HIV transmission. R esults were:Results from a randomized trial of the efficacy of zidovudine in preventing perinatal HIV transmission 1